COMT and Parkinson disease: Administration of L-DOPA, catechol-O-methyltransferase (COMT) inhibitors, monoamine oxidase inhibitors, amantadine, and dopamine agonists can effectively relieve the symptoms of PD, but it barely delays the loss of dopaminergic neurons [12,13].